MDxHealth (MDXH) Cash & Current Investments (2019 - 2026)

MDxHealth has reported Cash & Current Investments for 8 years, with the latest figure at $43.2 million in Q1 2026.

• Quarterly Cash & Current Investments fell 34.29% year-over-year to $43.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.2 million (down 34.29% YoY) and the FY2025 annual result came in at $47.3 million, changed 0.0% from the prior year.
• Cash & Current Investments advanced to $43.2 million in Q1 2026 per MDXH's latest filing, from $29.5 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $65.7 million in Q1 2025 and troughed at $33081.0 in Q2 2025.
• A 5-year average of $33.2 million and a median of $32.4 million in 2023 frame the typical range for Cash & Current Investments.
• The widest YoY moves for Cash & Current Investments: up 353.1% in 2025, down 99.85% in 2025.
• Over 5 years, Cash & Current Investments stood at $17.3 million in 2022, then soared by 30.44% to $22.6 million in 2023, then surged by 109.55% to $47.3 million in 2024, then plunged by 37.56% to $29.5 million in 2025, then soared by 46.12% to $43.2 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $43.2 million, $29.5 million, and $32.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.